HUM
35
6
CVX
23
7
FOX
30
6
PSX
40
3
JNJ
30
6
GWW
46
-4
VNO
54
-2
D
37
5
MUR
30
5
AVGO
69
-7
HAL
31
2
ABBV
70
2
EOG
46
5
TGNA
56
3
GOOGL
66
5
ALL
47
4
QCOM
78
-6
DVN
18
-2
MTB
57
8
FIS
51
-4
HUM
35
6
CVX
23
7
FOX
30
6
PSX
40
3
JNJ
30
6
GWW
46
-4
VNO
54
-2
D
37
5
MUR
30
5
AVGO
69
-7
HAL
31
2
ABBV
70
2
EOG
46
5
TGNA
56
3
GOOGL
66
5
ALL
47
4
QCOM
78
-6
DVN
18
-2
MTB
57
8
FIS
51
-4
Financhill
Back

Sarepta Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
43

SRPT
Sarepta Therapeutics

Last Price:
160.73
Seasonality Move:
13.83%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
43
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $123.56. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $123.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.66 Sell
Relative Strength Index (14 RSI): 50.38 Buy
Chaikin Money Flow: 1128064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (118.42 - 129.08) Sell
Bollinger Bands (100): (120.21 - 131.53) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 121.23 Buy
20-day SMA: 121.86 Buy
50-day SMA: 125 Sell
200-day SMA: 114.69 Buy
8-day EMA: 121.07 Buy
20-day EMA: 122.55 Buy
50-day EMA: 124.12 Sell
200-day EMA: 119.07 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.04 per share, an increase next quarter of $1.33 per share, an increase this year of $5.96 per share, and an increase next year of $5.92 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):